Middle East & Africa Radiation Oncology Market Forecast to 2031 - Regional Analysis - by Types and Application

The Middle East & Africa radiation oncology market was valued at US$ 172.24 million in 2023 and is expected to reach US$ 304.71 million by 2031; it is estimated to record a CAGR of 7.4% from 2023 to 2031.

Technological Advancement in Radiation Oncology Bolsters Middle East & Africa Radiation Oncology Market

Radiotherapy focuses on destroying the cancerous cells maximum sparing of healthy cells which was achieved over the period of time owing to the advancement in imaging technology such as magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET) and others. These imaging technologies helps in identifying the tumors cells along with its exact position and size which led to the development of 3D conformal radiotherapy. Over the period of time, there is constant development in radiotherapy technologies as mentioned below

Flash Therapy: It is being discussed among healthcare professionals, rather than days or weeks the entire dose of massive radiation is delivered at once very quickly. The healthy cells recover well over the period of time and killing only cancer cells. It is under study and if it proves to be safe and effective it can be revolutionary radiation therapy in coming years.

Image-guided radiation therapy (IGRT): This technology allows for real-time imaging of the tumor and surrounding healthy tissue before each treatment session, ensuring that the radiation beams are accurately targeted at the tumor and minimizing damage to nearby organs.

Intensity-modulated radiation therapy (IMRT): IMRT allows for the delivery of varying intensities of radiation to different parts of the tumor, allowing for better dose distribution and sparing of healthy tissue.

Stereotactic body radiation therapy (SBRT): This technology delivers high doses of radiation to small, well-defined tumors in a limited number of treatment sessions, leading to better local control of the tumor.

Proton therapy: Proton therapy uses protons instead of traditional X-rays to deliver radiation to the tumor, allowing for more precise targeting of the tumor and sparing of healthy tissue.

Adaptive radiation therapy: This technology allows for adjustments to the treatment plan based on changes in the tumor size or position during the course of treatment, ensuring that the radiation dose is always optimized for maximum effectiveness.

Moreover, increasing integration of artificial intelligence (AI) in cancer treatment for treatment planning, labelling anatomy patient CT scan images, and others. AI will help to cater to the patient's requirements instantly by offering required solutions during the course of treatment. Additionally, various radiation therapy equipment is integrated with AI which will benefit the patient and healthcare professional both.

For Instance, In May 2024, Elekta launched its latest linear accelerator (linac), Evo, a CT-Linac with new high-definition AI enhanced imaging, capable of delivering offline and online adaptive radiation therapy as well as improved standard image-guided radiation therapy treatments. Therefore, development in radiotherapy technologies and increasing integration of artificial intelligence is expected to expedite the radiation oncology market growth in coming years.

Middle East & Africa Radiation Oncology Market Overview

Over the past 50 years, Saudi Arabia has pioneered cancer care services in the Gulf region through several significant accomplishments. Progress in various cancer treatment areas aligns with its Vision 2030. Currently, Saudi Arabia has ~60 licensed radiation oncologists or clinical oncologists for treating patients with radiation therapy. The Saudi Proton Therapy Center at King Fahad Medical City in Riyadh became the first proton therapy facility in the Kingdom and the Arab world. The Saudi Fund for Development (SFD) opened the Saudi Radiotherapy Center for Cancer Patients at King Abdullah University Hospital in the northern Jordanian city of Ar-Ramtha in July 2021. This center helps over 1,200 cancer patients every year by providing essential services and enhancing healthcare in the northern part of Jordan.

Middle East & Africa Radiation Oncology Market Segmentation

The Middle East & Africa radiation oncology market is categorized into types, application, and country.

• Based on types, the Middle East & Africa radiation oncology market is bifurcated into external beam radiation therapy and internal beam radiation therapy. The external beam radiation therapy segment held a larger market share in 2023.
• In terms of application, the Middle East & Africa radiation oncology market is segmented into breast cancer, prostate cancer, lung cancer, head and neck cancer, cervical cancer, and others. The breast cancer segment held the largest market share in 2023.
• By country, the Middle East & Africa radiation oncology market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. The Rest of Middle East & Africa dominated the Middle East & Africa radiation oncology market share in 2023.

Varian Medical Systems Inc, Elekta AB, Accuray Incorporated, IBA Worldwide (Ion Beam Applications SA), Becton Dickinson and Co, Perspective Therapeutics Inc, Nordion, Mevion Medical Systems, NTP RADIOISOTOPES, Mallinckrodt Plc, Provision Healthcare, Panacea Medical Technologies Pvt. Ltd, and Curium are some of the leading companies operating in the Middle East & Africa radiation oncology market.

Reasons to Buy

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa radiation oncology market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa radiation oncology market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the Middle East & Africa radiation oncology market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.